• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑源性神经营养因子可预防阿尔茨海默病中与tau相关的神经退行性变。

Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.

作者信息

Jiao S-S, Shen L-L, Zhu C, Bu X-L, Liu Y-H, Liu C-H, Yao X-Q, Zhang L-L, Zhou H-D, Walker D G, Tan J, Götz J, Zhou X-F, Wang Y-J

机构信息

Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.

Cadre Ward, Department of Neurology, Bethune International Peace Hospital, Shijiazhuang, China.

出版信息

Transl Psychiatry. 2016 Oct 4;6(10):e907. doi: 10.1038/tp.2016.186.

DOI:10.1038/tp.2016.186
PMID:27701410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5315549/
Abstract

Reduced expression of brain-derived neurotrophic factor (BDNF) has a crucial role in the pathogenesis of Alzheimer's disease (AD), which is characterized with the formation of neuritic plaques consisting of amyloid-beta (Aβ) and neurofibrillary tangles composed of hyperphosphorylated tau protein. A growing body of evidence indicates a potential protective effect of BDNF against Aβ-induced neurotoxicity in AD mouse models. However, the direct therapeutic effect of BDNF supplement on tauopathy in AD remains to be established. Here, we found that the BDNF level was reduced in the serum and brain of AD patients and P301L transgenic mice (a mouse model of tauopathy). Intralateral ventricle injection of adeno-associated virus carrying the gene encoding human BDNF (AAV-BDNF) achieved stable expression of BDNF gene and restored the BDNF level in the brains of P301L mice. Restoration of the BDNF level attenuated behavioral deficits, prevented neuron loss, alleviated synaptic degeneration and reduced neuronal abnormality, but did not affect tau hyperphosphorylation level in the brains of P301L mice. Long-term expression of AAV-BDNF in the brain was well tolerated by the mice. These findings suggest that the gene delivery of BDNF is a promising treatment for tau-related neurodegeneration for AD and other neurodegenerative disorders with tauopathy.

摘要

脑源性神经营养因子(BDNF)表达降低在阿尔茨海默病(AD)的发病机制中起关键作用,AD的特征是由β-淀粉样蛋白(Aβ)组成的神经炎性斑块和由过度磷酸化的tau蛋白组成的神经原纤维缠结的形成。越来越多的证据表明BDNF对AD小鼠模型中Aβ诱导的神经毒性具有潜在的保护作用。然而,BDNF补充剂对AD中tau蛋白病的直接治疗效果仍有待确定。在这里,我们发现AD患者和P301L转基因小鼠(tau蛋白病小鼠模型)的血清和脑中BDNF水平降低。向侧脑室内注射携带编码人BDNF基因的腺相关病毒(AAV-BDNF)可使BDNF基因稳定表达,并恢复P301L小鼠脑中的BDNF水平。BDNF水平恢复可减轻行为缺陷、防止神经元丢失、减轻突触退化并减少神经元异常,但不影响P301L小鼠脑中tau蛋白的过度磷酸化水平。小鼠对脑中AAV-BDNF 的长期表达耐受性良好。这些发现表明,BDNF的基因递送是治疗AD和其他伴有tau蛋白病的神经退行性疾病中tau相关神经变性的一种有前景的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/7de4d66b7148/tp2016186f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/59d48d29aebe/tp2016186f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/5c7ffff60e0b/tp2016186f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/18d643cb13c7/tp2016186f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/6b853e8ffe5f/tp2016186f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/c152201762d1/tp2016186f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/7de4d66b7148/tp2016186f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/59d48d29aebe/tp2016186f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/5c7ffff60e0b/tp2016186f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/18d643cb13c7/tp2016186f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/6b853e8ffe5f/tp2016186f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/c152201762d1/tp2016186f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5992/5315549/7de4d66b7148/tp2016186f6.jpg

相似文献

1
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.脑源性神经营养因子可预防阿尔茨海默病中与tau相关的神经退行性变。
Transl Psychiatry. 2016 Oct 4;6(10):e907. doi: 10.1038/tp.2016.186.
2
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.在阿尔茨海默病的动物和细胞模型中,tau蛋白下调脑源性神经营养因子(BDNF)的表达。
Neurobiol Aging. 2016 Dec;48:135-142. doi: 10.1016/j.neurobiolaging.2016.08.020. Epub 2016 Aug 31.
3
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.神经营养肽能化合物慢性口服治疗对阿尔茨海默病三重转基因小鼠模型的疾病修饰作用。
Neurobiol Dis. 2014 Nov;71:110-30. doi: 10.1016/j.nbd.2014.07.001. Epub 2014 Jul 15.
4
In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.表达脑源性神经营养因子的间充质干细胞对APP/PS1小鼠原代培养神经元神经退行性变影响的体外验证
Neuroscience. 2015 Oct 29;307:37-50. doi: 10.1016/j.neuroscience.2015.08.011. Epub 2015 Aug 20.
5
Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.神经肽-1可改善阿尔茨海默病小鼠模型的学习和记忆缺陷,增加大脑中脑源性神经营养因子的表达,并减少β-淀粉样蛋白斑块。
Neurobiol Aging. 2014 May;35(5):990-1001. doi: 10.1016/j.neurobiolaging.2013.10.091. Epub 2013 Oct 29.
6
Neuroprotective brain-derived neurotrophic factor signaling in the TAU-P301L tauopathy zebrafish model.在 TAU-P301L tauopathy 斑马鱼模型中具有神经保护作用的脑源性神经营养因子信号。
Pharmacol Res. 2020 Aug;158:104865. doi: 10.1016/j.phrs.2020.104865. Epub 2020 May 14.
7
Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.小鼠tau蛋白病模型中CA1神经元的早期耗竭和晚期神经变性。
Brain Res. 2017 Jun 15;1665:22-35. doi: 10.1016/j.brainres.2017.04.002. Epub 2017 Apr 11.
8
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.在向中枢神经系统注射阿尔茨海默病脑源性病理性tau蛋白或合成突变型人tau蛋白原纤维后,绿色荧光蛋白标记的突变型人tau转基因小鼠出现tau蛋白病。
J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6.
9
Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.非阿尔茨海默病性tau蛋白病中前神经生长因子增加而脑源性神经营养因子减少。
Neurobiol Aging. 2014 Apr;35(4):926-33. doi: 10.1016/j.neurobiolaging.2013.08.029. Epub 2013 Oct 8.
10
Hippocampal BDNF expression in a tau transgenic mouse model.tau 转基因小鼠模型中海马脑源性神经营养因子表达。
Curr Alzheimer Res. 2012 May;9(4):406-10. doi: 10.2174/156720512800492468.

引用本文的文献

1
Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.阿尔茨海默病动物模型中突触前蛋白的蛋白质组学和非蛋白质组学变化:2015 - 2023年的一项荟萃分析
J Alzheimers Dis. 2025 Aug 1;107(2):13872877251362212. doi: 10.1177/13872877251362212.
2
BDNF gene therapy rescues neuronal function via unique and common transcriptional responses in Aβ and tau-driven Alzheimer's disease mouse models.脑源性神经营养因子基因疗法通过在β-淀粉样蛋白和tau蛋白驱动的阿尔茨海默病小鼠模型中独特且共同的转录反应来挽救神经元功能。
Biochem Biophys Rep. 2025 Jun 17;43:102089. doi: 10.1016/j.bbrep.2025.102089. eCollection 2025 Sep.
3

本文引用的文献

1
Higher brain BDNF gene expression is associated with slower cognitive decline in older adults.大脑中较高的脑源性神经营养因子(BDNF)基因表达与老年人认知能力下降较慢有关。
Neurology. 2016 Feb 23;86(8):735-41. doi: 10.1212/WNL.0000000000002387. Epub 2016 Jan 27.
2
Brain BDNF expression as a biomarker for cognitive reserve against Alzheimer disease progression.脑源性神经营养因子(BDNF)表达作为抵抗阿尔茨海默病进展的认知储备生物标志物。
Neurology. 2016 Feb 23;86(8):702-3. doi: 10.1212/WNL.0000000000002389. Epub 2016 Jan 27.
3
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
The promise of gene therapy in common types of dementia.
基因疗法在常见类型痴呆症中的前景。
Bioimpacts. 2025 Apr 21;15:30795. doi: 10.34172/bi.30795. eCollection 2025.
4
Advances in research on the pathogenesis and signaling pathways associated with postoperative delirium (Review).术后谵妄相关发病机制及信号通路的研究进展(综述)
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13585. Epub 2025 Jun 6.
5
Serum BDNF and progression to MCI in cognitively normal older adults: A prospective cohort study.血清脑源性神经营养因子与认知正常老年人进展为轻度认知障碍:一项前瞻性队列研究。
J Prev Alzheimers Dis. 2025 Aug;12(7):100210. doi: 10.1016/j.tjpad.2025.100210. Epub 2025 May 24.
6
A novel allosteric GCase modulator prevents Tau accumulation in GBA1 and GBA1 cellular models.一种新型变构葡糖脑苷脂酶调节剂可防止GBA1及GBA1细胞模型中tau蛋白积聚。
Sci Rep. 2025 May 21;15(1):17646. doi: 10.1038/s41598-025-02346-8.
7
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum.多队列脑脊液蛋白质组学确定了阿尔茨海默病连续体中的强大分子特征。
Neuron. 2025 May 7;113(9):1363-1379.e9. doi: 10.1016/j.neuron.2025.02.014. Epub 2025 Mar 14.
8
Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer's disease.兴奋性和抑制性神经元对阿尔茨海默病的恢复力和抵抗力的分子特征。
bioRxiv. 2025 Jan 15:2025.01.13.632801. doi: 10.1101/2025.01.13.632801.
9
Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy.淀粉样β蛋白和tau蛋白磷酸化以及RhoA活性诱导阿尔茨海默病的分子机制:RhoA/ Rho相关蛋白激酶抑制剂用于神经元治疗的前景
Cells. 2025 Jan 10;14(2):89. doi: 10.3390/cells14020089.
10
Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research.神经成像技术、基因治疗与肠道微生物群:阿尔茨海默病研究中的前沿进展与综合应用
Front Aging Neurosci. 2024 Dec 3;16:1485657. doi: 10.3389/fnagi.2024.1485657. eCollection 2024.
外周生理状态下的β-淀粉样蛋白清除及其对阿尔茨海默病的治疗潜力。
Acta Neuropathol. 2015 Oct;130(4):487-99. doi: 10.1007/s00401-015-1477-1. Epub 2015 Sep 12.
4
Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by aβ1-42.脑源性神经营养因子改善由β1-42诱导的阿尔茨海默病大鼠模型中的学习缺陷。
PLoS One. 2015 Apr 7;10(4):e0122415. doi: 10.1371/journal.pone.0122415. eCollection 2015.
5
Huntington's disease is a four-repeat tauopathy with tau nuclear rods.亨廷顿病是一种四重复tau 病,具有 tau 核棒。
Nat Med. 2014 Aug;20(8):881-5. doi: 10.1038/nm.3617. Epub 2014 Jul 20.
6
Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.非阿尔茨海默病性tau蛋白病中前神经生长因子增加而脑源性神经营养因子减少。
Neurobiol Aging. 2014 Apr;35(4):926-33. doi: 10.1016/j.neurobiolaging.2013.08.029. Epub 2013 Oct 8.
7
Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice.早期 BDNF 治疗可改善 APP 转基因小鼠内嗅皮层的细胞丢失。
J Neurosci. 2013 Sep 25;33(39):15596-602. doi: 10.1523/JNEUROSCI.5195-12.2013.
8
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.帕金森病痴呆:α-突触核蛋白、tau 和淀粉样β 病理学的汇聚。
Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31.
9
Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci.腺相关病毒血清型 9 通过静脉内递送来介导缺血性脑卒中病灶和脑血管生成灶中的有效基因表达。
Stroke. 2013 Jan;44(1):252-4. doi: 10.1161/STROKEAHA.112.662965. Epub 2012 Dec 18.
10
Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.在 3xTg-AD 小鼠中基因敲低脑源性神经营养因子不会改变 Aβ 或 tau 病理学。
PLoS One. 2012;7(8):e39566. doi: 10.1371/journal.pone.0039566. Epub 2012 Aug 3.